Episodio 12. Los daneses tienen un plan

Episodio 12. Los daneses tienen un plan.

Protocolo diseñado para evaluar EEAA serios de varios JAKi en pacientes con AR versus anti TNF

Faquetti ML, Vallejo-Yagüe E, Cordtz R, Dreyer L, Burden AM (2023) JAK-inhibitors and risk on serious viral infection, venous thromboembolism and cardiac events in patients with rheumatoid arthritis: A protocol for a prevalent new-user cohort study using the Danish nationwide DANBIO register. PLoS ONE 18(7): e0288757. 10.1371/journal.pone.0288757

Merete Lund Hetland, DANBIO—powerful research database and electronic patient record, Rheumatology, Volume 50, Issue 1, January 2011, Pages 69–77, https://doi.org/10.1093/rheumatology/keq309

Entradas populares de este blog

Episodio 8. Simulando tofacitinib versus adalimumab. Datos de vida real potenciados.

Episodio 8. Simulando tofacitinib versus adalimumab. Datos de vida real potenciados. La base de datos OPAL de Australia es una verdadera joya. Comentamos un "ensayo clinico simulado" utilizando los pacientes con AR y sus HCEs comparando tofacitinib versus adalimumab y comparamos con recomendaciones EULAR y datos de un ECA de 2017. Deakin CT , De Stavola BL , Littlejohn G, et al. Comparative Effectiveness of Adalimumab vs Tofacitinib in Patients With Rheumatoid Arthritis in Australia. JAMA Netw Open. 2023;6(6):e2320851. doi:10.1001/jamanetworkopen.2023.20851 https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2806589 Littlejohn GO, Tymms KE, Smith T, Griffiths HT. Using big data from real-world Australian rheumatology encounters to enhance clinical care and research. Clin Exp Rheumatol . 2020;38(5):874-880. https://pubmed.ncbi.nlm.nih.gov/31820719/ Fleischmann R, Mysler ...

Episodio 19: Primer sintoma de espondilitis

Episodio 19: Primer sintoma de espondilitis Investigadores españoles y mexicanos examinan las cohortes RESPONGISER y RESPONDIA en pos de establecer los primeros sintomas y signos de las distintas espondiloartropatias Puche-Larrubia MÁ, Ladehesa-Pineda L, Vázquez-Mellado J, et al. Identification of the first signs or symptoms in different spondyloarthritis subtypes and their association with HLA-B27: data from REGISPONSER and RESPONDIA registries. RMD Open 2023;9:e003235. doi: 10.1136/ rmdopen-2023-003235 E. Collantes, P. Zarco, E. Muñoz, X. Juanola, J. Mulero, J. L. Fernández-Sueiro, J. C. Torre-Alonso, J. Gratacós, C. González, E. Batlle, P. Fernández, L. F. Linares, E. Brito, L. Carmona, Disease pattern of spondyloarthropathies in Spain: description of the first national registry (REGISPONSER)—extended report, Rheumatology , Volume 46, Issue 8, August 2007, Pages 1309–1315, https://doi.org/10.1093/rheumatology/kem084 Janitzia Vázquez-Mellado a , P...

Episodio 5. Guias y vagos

Episodio 5. Guias y vagos. https://pod.link/1688456486 OP0234 2023 UPDATE OF EULAR RECOMMENDATIONS FOR THE TREATMENT OF SYSTEMIC SCLEROSIS. https://ard.bmj.com/content/82/Suppl_1/154 Research Update: Using Vagus Nerve Stimulation for Rheumatic Disease. April 8, 2023 • By Mary Beth Nierengarten . https://www.the-rheumatologist.org/article/research-update-using-vagus-nerve-stimulation-for-rheumatic-disease/ ClinicalTrials.gov is a database of privately and publicly funded clinical studies conducted around the world. https://clinicaltrials.gov/

Reumatown Blog

Buscar este blog